Disclosures for "Infusion-related Costs for HyQvia Compared to Hizentra in Chronic Inflammatory Demyelinating Polyradiculoneuropathy "
-
Dr. KHANDELWAL has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. KHANDELWAL has stock in Takeda Pharmaceuticals.
-
Mr. Farahbakhshian has received personal compensation for serving as an employee of Takeda Pharmaceutical Company Limited. Mr. Farahbakhshian has stock in Takeda Pharmaceutical Company Limited.
-
Ms. Loos has nothing to disclose.
-
Mr. Soyemi has nothing to disclose.
-
Dr. Taylor has nothing to disclose.
-
Dr. Riaz has received personal compensation for serving as an employee of Takeda Pharmaceuticals.